Gray D Shaw

This inventor holds 22 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Cancer Treatment. Top assignees: Genetics Institute, Inc., Wyeth, Other. Active years: 1990-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gray D Shaw. Retrieved from https://idiyas.com/inventor/gray-d-shaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 2)

% Patents Active = 54.5

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 691(Granted Patents)

Location History:

Bedford, MA (US) (1990 - 1992)
Concord, MA (US) (1998)
Cambridge, MA (US) (2001 - 2012)
Redwood City, CA (US) (2014)
Milton, MA (US) (2005 - 2016)
Half Moon Bay, CA (US) (2019)

Company Filing History:

16 out of 392

Genetics Institute, Inc.

4 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2025

Loading Chart...

Areas of Expertise:

P-Selectin Ligand

Fusion Proteins

Mocarhagin

Therapeutic Uses

Cancer Treatment

Thrombosis

Platelet Glycoprotein

Nucleic Acids

Site-Specific Conjugation

Selectin Ligand

Polypeptides

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12195518 - Methods for treating cancer using soluble forms of PSGL-1 and fusion molecules thereof (2025-01-14),

2. 10421796 - Variants of IgG Fc with limited amine groups (2019-09-24),

3. 10214578 - Variants of IgG-Fc fusion that provide for site-specific conjugation at the N-terminus (2019-02-26),

4. 9266923 - Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets (2016-02-23),

5. 8889628 - Soluble tandem selectin glycoprotein ligand molecules (2014-11-18),

6. 8232252 - P-selectin ligand protein (2012-07-31),

7. 7927835 - Nucleic acids encoding P-selectin ligand fusion proteins (2011-04-19),

8. 7727535 - Platelet glycoprotein Ib alpha variant fusion polypeptides and methods of use thereof (2010-06-01),

9. 7563760 - P-selectin ligand protein (2009-07-21),

10. 7405272 - Selectin ligand interactor cytoplasmic (SLIC-1), a P-selectin glycoprotein ligand (PSGL-1) binding protein (2008-07-29),

11. 7252820 - Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof (2007-08-07),

12. 7049128 - Platelet glycoprotein Ibα fusion polypeptides and methods of use thereof (2006-05-23),

13. 6991796 - Platlet glycoprotein IBα fusion polypeptides and methods of use thereof (2006-01-31),

14. 6881404 - Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof (2005-04-19),

15. 6852497 - Methods of identifying compounds which inhibit binding of SLIC-1 to PSGL-1 (2005-02-08),

Title: The Innovative Journey of Gray D Shaw

Introduction: Gray D Shaw, a distinguished inventor hailing from Milton, MA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Gray D Shaw's latest patents include a cutting-edge software application for data encryption and a revolutionary design for a solar-powered heating system.

Career Highlights: With a career spanning over two decades, Gray D Shaw has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has been recognized with multiple awards and accolades in the industry.

Collaborations: Throughout his career, Gray D Shaw has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Gray D Shaw's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of technology. His continued dedication to pushing the boundaries of what is possible ensures that his legacy will endure for years to come.

Profile summary based on public USPTO records.